High-sensitive troponin T is used to help diagnose myocardial infarction. The first high-sensitive troponin on the market was Elecsys Troponin T Gen 5, which was cleared by the FDA in January 2017. Since then, over 300 healthcare organizations and institutions across the country have adopted high-sensitive troponin. But what has that integration looked like?
To find out, this three-part series, MI Detecton in Practice: Troponin T Gen 5, takes an in-depth look at the adoption and impact of high-sensitive troponin T Gen 5 from an emergency department, laboratory, and cardiology perspective.
Sponsored by
